Board of Directors

William T. Abraham, MD, FACP, FACC, FAHA, FESC

Professor of Medicine, Physiology, and Cell Biology
Chair of Excellence in Cardiovascular Medicine
Director, Division of Cardiovascular Medicine
Deputy Director, Davis Heart and Lung Research Institute
The Ohio State University

Wilfred Jaeger

Three Arch Partners

B. Kristine Johnson

General Partner
Affinity Capital Management

Kirk Nielsen

Managing Director
Versant Ventures

Jonathan A. Rennert

Chief Executive Officer
ZOLL Medical Corporation

Peter Sommerness

President and CEO
Respicardia®, Inc.

Thomas D. Weldon

Chairman and Managing Director
Accuitive Medical Ventures

1 in 3 people with heart failure have Central Sleep Apnea and stop breathing during the night. Talk to your doctor about the remedē® System clinical study to see if you qualify.
Send us an email at or read about our clinical study at


Respicardia®, Inc.
12400 Whitewater Dr., Suite 150
Minnetonka, MN 55343 USA
See Map
Phone: +1-952-540-4470
©2018 Respicardia®, Inc. The remedē® System has received FDA and CE Mark approvals. See Patents